MBA
LAW
LANGUAGES

JAVELIN PHARMACEUTIC JAV (AMEX)

$ 1.77

17:39

Sponsored by

Change: +0.27 (+18.00%)
Volume: 327,600

Avg. Volume:	268285
P/E Ratio:	0
EPS (Annual):	-0.73
Profit Margin:
Dividend & Yield(Annual):	0%
Shares Outstanding:	60,520
Institutional Shareholders:	30.07%

Last:	1.77
Change:	+0.27 (+18.00%)
Prev. Close:	1.50
Open:	1.42
Day's Range:	1.42 - 1.77
52wk Range:	0.73 - 5.74
Market Value:	69,710
Beta:

12-month EPS Change:	0.00%
Total Return Last 12 Months:	-68.42%
Total Return Last 3 Years:	-37.26%
Total Return Last 5 Years:	-54.13%
5-Year Revenue Growth Rate:	0.00%
5-Year Dividend Growth Rate:	0.00%
5-Year EPS Growth Rate:	0.00%

Headlines on JAV

Alert me

Javelin Pharmaceuticals CEO buys shares

(NEW YORK)The chief executive of drug developer Javelin Pharmaceuticals Inc. bought 30,000 shares of stock, according to a Securities and Exchange Commission filing Thursday.READ MORE

Jun 27, 2008 3:55PM

Keywords: JAV